We are excited to announce our 5 expert presenters:

• Mark Sculpher (Centre for Health Economics, University of York)
  
• Neil Hawkins (University of Glasgow)
  
• Jan McKendrick (Senior Director at PRMA Consulting)
  
• Anja Schiel (Senior Advisor and Statistician at the Norwegian Medicines Agency - NoMA)
  
• Jonathan Alsop (Director at Numerus)
  

Venue: AstraZeneca, Gothenburg, Sweden

For further details or to register: http://www.psiweb.org and click on events

This 2-day course will provide an introduction to the methods of health technology assessment.  There will be a focus on how to estimate the costs and benefits of new interventions and analysis undertaken to support decisions about whether new interventions should be funded by health systems.  The first day will include sessions on policy context and basic economic evaluation methods, as well as lectures on health measurement and valuation for HTA, evidence synthesis and decision analysis.  There will also be exercises to confirm participants’ understanding of key concepts. The second day will focus on sharing case studies and discussing key statistical challenges in HTA such as treatment switching, extrapolation, and network meta-analysis.  Attendees will be encouraged to share their own HTA experiences. 

The following topics will be covered:
• HTA Policy
• Methods of economic evaluation
• Critical review of HTA publications
• Evidence synthesis
• Measuring and valuing health
• HTA decision models
• Industry HTA case studies
• Key statistical challenges in HTA